Launchpad Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
December 12, 2022
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$30,000,000

Company Info
Company Description
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Market
Cancer therapeutics
Location
Cambridge, MA, USA
Coinvestors
Black Diamond Therapeutics, New Enterprise Associates, Versant Ventures

Links